FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1897522047> ?p ?o ?g. }

• W1897522047 abstract "Androgen deprivation therapy (ADT) with luteinizing hormone releasing hormone (LHRH) agonists is an effective initial therapy for men with advanced prostate cancer. LHRH agonists are usually administered indefinitely at a fixed interval.We recruited men with advanced prostate cancer who had been on fixed-schedule injections of an LHRH agonist for ≥1 year and had castrate serum testosterone [<1.75 nmol/l (approx. 50 ng/ml)]. Testosterone levels were measured at 6-week intervals and ADT was withheld until testosterone levels were no longer in the castrate range and then reinstituted. Time to reinstitution of ADT was the primary outcome and was analyzed by the Kaplan-Meier method; Cox regression was used to identify factors predicting delay in reinstitution of treatment. Influence on quality-of-life (QoL) was evaluated by the Expanded Prostate Index Composite (EPIC).Forty-six evaluable men who had received LHRH agonist injections every 12 weeks were recruited. Median time to testosterone recovery (defined as testosterone outside the defined castrate level) after previous injection was >1 year. In univariable analysis, lower baseline testosterone [≤1 vs. >1 nmol/l (approx. 30 ng/dl)] and longer time on ADT (>5 vs. ≤5 years) predicted for prolonged time to testosterone recovery, but only lower baseline testosterone remained significant in multivariable analysis (Hazard Ratio = 5.2, P = 0.03). Overall EPIC scores remained stable but improvement from baseline was observed in the hormonal domain (P = 0.002). Median per-patient saving in cost was approximately USD 3,100 (1,050-6,200).Testosterone-guided ADT reduces exposure to LHRH agonists, with reduction in cost and improvement in some symptoms from ADT. Testosterone-guided ADT should be considered an alternative to fixed schedule treatment by physicians and policy makers." @default.
• W1897522047 created "2016-06-24" @default.
• W1897522047 creator A5021202830 @default.
• W1897522047 creator A5024042137 @default.
• W1897522047 creator A5031817257 @default.
• W1897522047 creator A5036682519 @default.
• W1897522047 creator A5044972820 @default.
• W1897522047 creator A5048283327 @default.
• W1897522047 creator A5063846121 @default.
• W1897522047 creator A5085333470 @default.
• W1897522047 creator A5089017943 @default.
• W1897522047 creator A5090147766 @default.
• W1897522047 date "2015-11-02" @default.
• W1897522047 modified "2023-10-12" @default.
• W1897522047 title "Study of testosterone-guided androgen deprivation therapy in management of prostate cancer" @default.
• W1897522047 cites W1567228155 @default.
• W1897522047 cites W1971251499 @default.
• W1897522047 cites W1980789427 @default.
• W1897522047 cites W2004509655 @default.
• W1897522047 cites W2016215015 @default.
• W1897522047 cites W2018463440 @default.
• W1897522047 cites W2024865991 @default.
• W1897522047 cites W2025053238 @default.
• W1897522047 cites W2041238968 @default.
• W1897522047 cites W2051132824 @default.
• W1897522047 cites W2054167621 @default.
• W1897522047 cites W2059440808 @default.
• W1897522047 cites W2076445987 @default.
• W1897522047 cites W2081052928 @default.
• W1897522047 cites W2097930057 @default.
• W1897522047 cites W2098998490 @default.
• W1897522047 cites W2099640898 @default.
• W1897522047 cites W2104748844 @default.
• W1897522047 cites W2115201106 @default.
• W1897522047 cites W2118786285 @default.
• W1897522047 cites W2125566855 @default.
• W1897522047 cites W2137282952 @default.
• W1897522047 cites W2140806188 @default.
• W1897522047 cites W2142773939 @default.
• W1897522047 cites W2151029963 @default.
• W1897522047 cites W2401709656 @default.
• W1897522047 cites W4241174091 @default.
• W1897522047 cites W4320996296 @default.
• W1897522047 doi "https://doi.org/10.1002/pros.23117" @default.
• W1897522047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26768279" @default.
• W1897522047 hasPublicationYear "2015" @default.
• W1897522047 type Work @default.
• W1897522047 sameAs 1897522047 @default.
• W1897522047 citedByCount "2" @default.
• W1897522047 countsByYear W18975220472016 @default.
• W1897522047 countsByYear W18975220472023 @default.
• W1897522047 crossrefType "journal-article" @default.
• W1897522047 hasAuthorship W1897522047A5021202830 @default.
• W1897522047 hasAuthorship W1897522047A5024042137 @default.
• W1897522047 hasAuthorship W1897522047A5031817257 @default.
• W1897522047 hasAuthorship W1897522047A5036682519 @default.
• W1897522047 hasAuthorship W1897522047A5044972820 @default.
• W1897522047 hasAuthorship W1897522047A5048283327 @default.
• W1897522047 hasAuthorship W1897522047A5063846121 @default.
• W1897522047 hasAuthorship W1897522047A5085333470 @default.
• W1897522047 hasAuthorship W1897522047A5089017943 @default.
• W1897522047 hasAuthorship W1897522047A5090147766 @default.
• W1897522047 hasConcept C121608353 @default.
• W1897522047 hasConcept C126322002 @default.
• W1897522047 hasConcept C126894567 @default.
• W1897522047 hasConcept C134018914 @default.
• W1897522047 hasConcept C207103383 @default.
• W1897522047 hasConcept C2776235491 @default.
• W1897522047 hasConcept C2777899217 @default.
• W1897522047 hasConcept C2777911890 @default.
• W1897522047 hasConcept C2778575703 @default.
• W1897522047 hasConcept C2778894405 @default.
• W1897522047 hasConcept C2779093440 @default.
• W1897522047 hasConcept C2779279991 @default.
• W1897522047 hasConcept C2780192828 @default.
• W1897522047 hasConcept C44249647 @default.
• W1897522047 hasConcept C50382708 @default.
• W1897522047 hasConcept C71315377 @default.
• W1897522047 hasConcept C71924100 @default.
• W1897522047 hasConceptScore W1897522047C121608353 @default.
• W1897522047 hasConceptScore W1897522047C126322002 @default.
• W1897522047 hasConceptScore W1897522047C126894567 @default.
• W1897522047 hasConceptScore W1897522047C134018914 @default.
• W1897522047 hasConceptScore W1897522047C207103383 @default.
• W1897522047 hasConceptScore W1897522047C2776235491 @default.
• W1897522047 hasConceptScore W1897522047C2777899217 @default.
• W1897522047 hasConceptScore W1897522047C2777911890 @default.
• W1897522047 hasConceptScore W1897522047C2778575703 @default.
• W1897522047 hasConceptScore W1897522047C2778894405 @default.
• W1897522047 hasConceptScore W1897522047C2779093440 @default.
• W1897522047 hasConceptScore W1897522047C2779279991 @default.
• W1897522047 hasConceptScore W1897522047C2780192828 @default.
• W1897522047 hasConceptScore W1897522047C44249647 @default.
• W1897522047 hasConceptScore W1897522047C50382708 @default.
• W1897522047 hasConceptScore W1897522047C71315377 @default.
• W1897522047 hasConceptScore W1897522047C71924100 @default.
• W1897522047 hasLocation W18975220471 @default.
• W1897522047 hasLocation W18975220472 @default.
• W1897522047 hasOpenAccess W1897522047 @default.
• W1897522047 hasPrimaryLocation W18975220471 @default.

• next